197 related articles for article (PubMed ID: 24816171)
1. Dengue virus-infected human dendritic cells reveal hierarchies of naturally expressed novel NS3 CD8 T cell epitopes.
Piazza P; Campbell D; Marques E; Hildebrand WH; Buchli R; Mailliard R; Rinaldo CR
Clin Exp Immunol; 2014 Sep; 177(3):696-702. PubMed ID: 24816171
[TBL] [Abstract][Full Text] [Related]
2. Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus.
Lim MQ; Kumaran EAP; Tan HC; Lye DC; Leo YS; Ooi EE; MacAry PA; Bertoletti A; Rivino L
Front Immunol; 2018; 9():2225. PubMed ID: 30327651
[TBL] [Abstract][Full Text] [Related]
3. Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection.
Rivino L; Kumaran EA; Jovanovic V; Nadua K; Teo EW; Pang SW; Teo GH; Gan VC; Lye DC; Leo YS; Hanson BJ; Smith KG; Bertoletti A; Kemeny DM; MacAry PA
J Virol; 2013 Mar; 87(5):2693-706. PubMed ID: 23255803
[TBL] [Abstract][Full Text] [Related]
4. Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection.
Mathew A; Kurane I; Green S; Stephens HA; Vaughn DW; Kalayanarooj S; Suntayakorn S; Chandanayingyong D; Ennis FA; Rothman AL
J Virol; 1998 May; 72(5):3999-4004. PubMed ID: 9557687
[TBL] [Abstract][Full Text] [Related]
5. Dengue virus-specific CD4+ and CD8+ T lymphocytes target NS1, NS3 and NS5 in infected Indian rhesus macaques.
Mladinich KM; Piaskowski SM; Rudersdorf R; Eernisse CM; Weisgrau KL; Martins MA; Furlott JR; Partidos CD; Brewoo JN; Osorio JE; Wilson NA; Rakasz EG; Watkins DI
Immunogenetics; 2012 Feb; 64(2):111-21. PubMed ID: 21881953
[TBL] [Abstract][Full Text] [Related]
6. Identification of amino acids involved in recognition by dengue virus NS3-specific, HLA-DR15-restricted cytotoxic CD4+ T-cell clones.
Zeng L; Kurane I; Okamoto Y; Ennis FA; Brinton MA
J Virol; 1996 May; 70(5):3108-17. PubMed ID: 8627790
[TBL] [Abstract][Full Text] [Related]
7. Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1.
Duan Z; Guo J; Huang X; Liu H; Chen X; Jiang M; Wen J
J Med Virol; 2015 Jul; 87(7):1077-89. PubMed ID: 25777343
[TBL] [Abstract][Full Text] [Related]
8. T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.
Grifoni A; Voic H; Dhanda SK; Kidd CK; Brien JD; Buus S; Stryhn A; Durbin AP; Whitehead S; Diehl SA; De Silva AD; Balmaseda A; Harris E; Weiskopf D; Sette A
J Virol; 2020 May; 94(10):. PubMed ID: 32132233
[TBL] [Abstract][Full Text] [Related]
9. Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a.
Mathew A; Kurane I; Rothman AL; Zeng LL; Brinton MA; Ennis FA
J Clin Invest; 1996 Oct; 98(7):1684-91. PubMed ID: 8833919
[TBL] [Abstract][Full Text] [Related]
10. Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection.
Weiskopf D; Angelo MA; Sidney J; Peters B; Shresta S; Sette A
J Virol; 2014 Oct; 88(19):11383-94. PubMed ID: 25056881
[TBL] [Abstract][Full Text] [Related]
11. Immunoinformatics and molecular docking studies reveal potential epitope-based peptide vaccine against DENV-NS3 protein.
Tahir RA; Wu H; Rizwan MA; Jafar TH; Saleem S; Sehgal SA
J Theor Biol; 2018 Dec; 459():162-170. PubMed ID: 30291844
[TBL] [Abstract][Full Text] [Related]
12. Highly conserved epitopes of DENV structural and non-structural proteins: Candidates for universal vaccine targets.
Verma M; Bhatnagar S; Kumari K; Mittal N; Sukhralia S; Gopirajan At S; Dhanaraj PS; Lal R
Gene; 2019 May; 695():18-25. PubMed ID: 30738967
[TBL] [Abstract][Full Text] [Related]
13. Definition of an epitope on NS3 recognized by human CD4+ cytotoxic T lymphocyte clones cross-reactive for dengue virus types 2, 3, and 4.
Kurane I; Zeng L; Brinton MA; Ennis FA
Virology; 1998 Jan; 240(2):169-74. PubMed ID: 9454689
[TBL] [Abstract][Full Text] [Related]
14. Combination of Modified NS1 and NS3 as a Novel Vaccine Strategy against Dengue Virus Infection.
Kao YS; Yu CY; Huang HJ; Tien SM; Wang WY; Yang M; Anderson R; Yeh TM; Lin YS; Wan SW
J Immunol; 2019 Oct; 203(7):1909-1917. PubMed ID: 31451673
[TBL] [Abstract][Full Text] [Related]
15. Induction of specific and flavivirus--Cross-reactive CTLs by immunization with a single dengue virus-derived CTL epitope peptide.
Masaki H; Fujii Y; Wakasa-Morimoto C; Toyosaki-Maeda T; Irimajiri K; Tomura TT; Kurane I
Virus Res; 2009 Sep; 144(1-2):188-94. PubMed ID: 19427342
[TBL] [Abstract][Full Text] [Related]
16. Sustained Specific and Cross-Reactive T Cell Responses to Zika and Dengue Virus NS3 in West Africa.
Herrera BB; Tsai WY; Chang CA; Hamel DJ; Wang WK; Lu Y; Mboup S; Kanki PJ
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321308
[TBL] [Abstract][Full Text] [Related]
17. Distinct activation phenotype of a highly conserved novel HLA-B57-restricted epitope during dengue virus infection.
Townsley E; Woda M; Thomas SJ; Kalayanarooj S; Gibbons RV; Nisalak A; Srikiatkhachorn A; Green S; Stephens HA; Rothman AL; Mathew A
Immunology; 2014 Jan; 141(1):27-38. PubMed ID: 23941420
[TBL] [Abstract][Full Text] [Related]
18. Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8
Culshaw A; Ladell K; Gras S; McLaren JE; Miners KL; Farenc C; van den Heuvel H; Gostick E; Dejnirattisai W; Wangteeraprasert A; Duangchinda T; Chotiyarnwong P; Limpitikul W; Vasanawathana S; Malasit P; Dong T; Rossjohn J; Mongkolsapaya J; Price DA; Screaton GR
Nat Immunol; 2017 Nov; 18(11):1228-1237. PubMed ID: 28945243
[TBL] [Abstract][Full Text] [Related]
19. Definition of the region on NS3 which contains multiple epitopes recognized by dengue virus serotype-cross-reactive and flavivirus-cross-reactive, HLA-DPw2-restricted CD4+ T cell clones.
Okamoto Y; Kurane I; Leporati AM; Ennis FA
J Gen Virol; 1998 Apr; 79 ( Pt 4)():697-704. PubMed ID: 9568963
[TBL] [Abstract][Full Text] [Related]
20. Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities.
Livingston PG; Kurane I; Dai LC; Okamoto Y; Lai CJ; Men R; Karaki S; Takiguchi M; Ennis FA
J Immunol; 1995 Feb; 154(3):1287-95. PubMed ID: 7529799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
